Zenas BioPharma, Inc.
HealthcareNASDAQ:ZBIO · NASDAQ Global Select
+$2.04 today
Vol 1.32M · Avg 0.69M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+91.67%
Period High
$43.17
Period Low
$9.14
Latest
$19.80
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.59B
Trevi Therapeutics, Inc.
NASDAQ:TRVI
$2.02B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.62B
Novavax, Inc.
NASDAQ:NVAX
$1.46B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.36B
Inhibrx Biosciences, Inc.
NASDAQ:INBX
$1.35B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.21B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.13B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$856.09M
Upstream Bio, Inc.
UPB
$331.96M
What is the latest ZBIO filing?
The latest filing shown is 4 dated May 18, 2026.
How many recent filings does ZBIO have?
Intrinsic Alpha currently shows 20 recent filings for ZBIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.